Cholestyramine therapy for antibiotic-associated colitis.
D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001430:Bacteriocins / Q000378:metabolism; D002792:Cholestyramine Resin / Q000378:metabolism / Q000627:therapeutic use*; D003106:Colon / Q000382:microbiology*; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced* / Q000188:drug therapy; D004768:Enterotoxins / Q000378:metabolism; D006801:Humans
D000900:Anti-Bacterial Agents; D001430:Bacteriocins; D004768:Enterotoxins; D002792:Cholestyramine Resin